Targeting T cells to treat atherosclerosis: odyssey from bench to bedside

More than 150 years from the initial description of inflammation in atherosclerotic plaques, randomized clinical trials to test anti-inflammatory therapies in atherosclerosis have recently been initiated. Lymphocytes and macrophages are main participants in the inflammatory response in atheroscleros...

Descripción completa

Detalles Bibliográficos
Autores principales: Bullenkamp, Jessica, Dinkla, Sip, Kaski, Juan Carlos, Dumitriu, Ingrid E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907356/
https://www.ncbi.nlm.nih.gov/pubmed/27418972
http://dx.doi.org/10.1093/ehjcvp/pvw001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907356/
https://www.ncbi.nlm.nih.gov/pubmed/27418972
http://dx.doi.org/10.1093/ehjcvp/pvw001

Ejemplares similares